PURE Bioscience develops and markets antimicrobial products which provide solutions to the pathogen and hygienic control challenges faced in health and environmental fields. The company’s technology platform is based on stabilized ionic silver and its initial products contain silver dihydrogen citrate (SDC), a broad-spectrum, non-toxic antimicrobial agent which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is unique because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. For more information, visit the company’s website at www.purebio.com.